Curtis J Cranmer, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7573 State Route 54, Bath, NY 14810 Phone: 607-776-2247 Fax: 607-776-5919 |
Gurdeep S Kundlas, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7569 State Route 54, Bath, NY 14810 Phone: 607-776-2932 Fax: 607-776-3640 |
Donald R Weidner, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7573 State Route 54, Bath, NY 14810 Phone: 607-776-2247 Fax: 607-776-5919 |
Jessica R Otis, FNP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7573 State Route 54, Bath, NY 14810 Phone: 607-776-2247 |
Dr. Michelle L. Rougeux, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 115 Liberty St, Bath, NY 14810 Phone: 607-664-2156 Fax: 607-664-2152 |
Werner K Brammer, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7573 State Route 54, Keuka Family Practice, Bath, NY 14810 Phone: 607-776-2247 |
Dennis W O'connor, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7573 State Route 54, Bath, NY 14810 Phone: 607-776-2247 Fax: 607-776-5919 |
News Archive
Consumer advocates and some legislators were surprised and frustrated when California health officials recently refused a $6 million donation to help people re-up their Medi-Cal health coverage. Now two senators have proposed an unusual solution: a bill to force the state to accept the offer from The California Endowment (Gorman, 7/4).
Amidst the ongoing health-policy debate, Los Angeles surgeon Joel Aronowitz, M.D., founder of the Breast Preservation Foundation, furthered his organization's health education and quality of care mission by meeting Washington policymakers to discuss how health care reform can help breast cancer patients be informed of all their treatment choices and have access to more advanced techniques like skin-sparing mastectomy.
Isis Pharmaceuticals, Inc., the leader in RNA-targeted therapeutics, and Akcea Therapeutics, its wholly owned subsidiary, announced today that The New England Journal of Medicine (NEJM) has published positive clinical results from a Phase 2 clinical study evaluating volanesorsen (formerly ISIS-APOCIII Rx) in patients with very high to severely high triglycerides.
Terrorist attacks with chemical weapons are a real possibility, according to a study that appears in the online open access journal, Journal of Pharmacy Practice, published by SAGE.
A woman successfully treated for a recurrent Clostridium difficile infection with stool from an overweight donor rapidly gained weight herself afterwards, becoming obese, according to a case report published in the new journal Open Forum Infectious Diseases.
› Verified 1 days ago